Loading clinical trials...

Acupoint Massage Combined With Ear Point Pressing Beans | Clinical Trials | Clareo Health

COMPLETEDPHASE1

Acupoint Massage Combined With Ear Point Pressing Beans

Explore the Application Effect of Acupoint Massage Combined With Ear Point Pressing Beans in the Remission Stage of Asthma

NCT06650917•Hai'an Hospital of TCM001

View on ClinicalTrials.gov

Summary

Objective: To explore the application effect of acupoint massage combined with ear point pressing beans in the remission stage of asthma. Methods: 120 children with asthma in remission who were treated in pediatric outpatient department from January 2016 to October 2022 were randomly divided into experimental group and control group, with 60 cases in each group.The patients in both groups were treated with salmeterol and fluticasone inhalation powder once a day, twice a day. The patients in the control group were treated with acupoint massage on this basis. Acupoint massage once a day from Monday to Friday, lasting for 30 minutes each time.The patients in the experimental group were treated with ear point pressing beans on the basis of the control group. The ear point pressing beans is performed once a day from Monday to Friday. Changes in pulmonary function and asthma control were observed before and after treatment in the two groups were observed, and forced expiratory volume 1 second (FEV1),forced expiratory vital capacity (FVC), FEV1/FVC, asthma control test scale (ACT) score were compared.

Eligibility

Age

1 - 18 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•The patient met the diagnostic criteria of asthma remission in the Guidelines for prevention and treatment of bronchial asthma；
•1\~18 years old, course of disease \> 1 year;
•Patients with complete clinical data and able to cooperate with treatment.

Exclusion Criteria

•Patients with other cardiopulmonary system diseases or myasthenia gravis;
•Eczema, ulcer or other symptoms in the auricle or skin;
•Illiteracy, cognitive, language or communication disorders;
•The patient has taken medication for asthma treatment within 3 months.

Key Dates

Start Date

January 1, 2016

Primary Completion Date

October 1, 2022

Completion Date

December 1, 2022

Last Updated

October 21, 2024

Enrollment

120

ACTUAL participants

Conditions

Asthma

Interventions

the experiment group were treated acupoint massage combined with ear point pressing beans

BEHAVIORAL

the control group were treated with acupoint massage

BEHAVIORAL

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

NCT02327897

Asthma

View study

RECRUITINGNA

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 21, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Acupoint Massage Combined With Ear Point Pressing Beans

Inclusion Criteria

Exclusion Criteria

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma

To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma